Posters

Analysing dissatisfaction with a new diffractive trifocal IOL: Rayner RayOne®

Poster Details

First Author: C.Martin-Reyes SPAIN

Co Author(s):    F. Llovet-Osuna   J. Ortega-Usobiaga   A. Llovet-Rausell   J. Beltran-Sanz   F. Gonzalez-López   R. Bilbao-Calabuig     

Abstract Details

Purpose:

A prospective, multi-center, non-randomized clinical study was conducted to determine the visual outcomes as well as patient satisfaction with the Rayner RayOne® diffractive trifocal IOL

Setting:

Clinica Baviera, Spain. Baviera Group - AIER Eye Group

Methods:

Four hundred and forty-four eyes were enrolled in a prospective, multi-center, non-randomized clinical study to analyze the visual outcomes as well as patient satisfaction with the new Rayner trifocal IOL: the Rayner RayOne®. Patient satisfaction was analyzed using a questionnaire and conducting an in-depth analysis of the electronic medical records. Results were compared to our prior data with regards to Finevision® and ATLisa® trifocal IOLs.

Results:

Four hundred and forty-four eyes were implanted with the Rayner RayOne® trifocal IOL, and only 1.36% showed dissatisfaction features. Though some patients reported night halos and glare, only two patients reported significant positive dysphotopsia. One patient reported negative dysphotopsia. All patients were spectacle free for all distances. Dissatisfaction features were analyzed and compared to our prior data using Finevision® and ATLisa® trifocal IOLs.

Conclusions:

The RayOne trifocal IOL provided good visual performance in all distances, though there was a small group of patients who showed dissatisfaction. Having a sounded knowledge of what the reasons for dissatisfaction are might provide us with some key tools to improve patient outcomes.

Financial Disclosure:

... gains financially from competing product or procedure, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... is employed by a competing company, ... has significant investment interest in a company producing, developing or supplying product or procedure presented